Rhodotorula Fungemia of an Intensive Care Unit Patient and Review of Published Cases

Mycopathologia

Volumn 174, Issue 4, 2012, Pages 301-309

  Spiliopoulou, Anastasia ^a   Anastassiou, Evangelos D ^a   Christofidou, Myrto ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Antifungals; Fungemia; Rhodotorula mucilaginosa; Rhodotorula spp; Risk factors

Indexed keywords

RHODOTORULA MUCILAGINOSA;

EID: 84866273354     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9552-9     Document Type: Article

References (38)

1. Fell JW, Boekhout T, Fonseca A, Scorzetti G, Statzelli-Tallman A. Biodiversity and systematic of basidiomycetous yeasts as determined by large-unit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol. 2000; 50: 1351-71.
2. Galan-Sanchez F, Garcia-Martos P, Rodriguez-Ramos C, Marin-Casanova P, Mira-Gutierrez J. Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples. Mycopathologia. 1999; 145: 109-12.
3. Louria BD, Greenberg SM, Molander DW. Fungemia caused by certain nonpathogenic strains of the family Cryptococcaceae. N Engl J Med. 1960; 263: 1281-4.
4. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev. 1995; 8: 462-78.
5. Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011; 11: 142-51.
6. Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol. 2008; 25: 135-40.
7. Louria BD, Blevins A, Armstrong D, Burdick R, Lieberman P. Fungemia Caused by "Nonpathogenic" yeasts. Arch Intern Med. 1967; 119: 247-52.
8. Tuon FF, Duboc de Almeida G, Costa SF. Central venous catheter-related fungemia due to Rhodotorula spp.-a systematic review. Med Mycol. 2007; 45: 441-7.
9. Anatoliotaki M, Mantadakis E, Galanakis E, Samonis G. Rhodotorula species fungemia: a threat to the immunocompromised host. Clin Lab. 2003; 49: 49-55.
10. Samonis G, Anatoliotaki M, Apostolakou H, Maraki S, Mavroudis D, Georgoulias V. Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature. Infection. 2001; 29: 173-6.
11. Garcia-Suarez J, Gomez-Herruz P, Cuadros JA, Burgaleta C. Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses. 2011; 54: 318-24.
12. Mori T, Nakamura Y, Kato J, Sugita K, Murata M, Kamei K, Okamoto S. Fungemia due to Rhodotorulamucilaginosa after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2011;. doi: 10. 1111/j. 1399-3062. 2011. 00647. x.
13. Petrocheilou-Paschou V, Prifti H, Kostis E, Papadimitriou C, Dimopoulos MA, Stamatelopoulos S. Rhodotorula septicemia: case report and minireview. Clin Microbiol Infect. 2001; 7: 100-2.
14. Navarro JT, Lauzurica R, Giménez M. Rhodotorula rubra infection in a kidney transplant patient with pancytopenia. Haematologica. 2001; 86: 111.
15. Chung JW, Kim BN, Kim YS. Central venous catheter-related Rhodotorularubra fungemia. J Infect Chemother. 2002; 8: 109-10.
16. Krcmery V, Laho L, Huttova M, Ondrusova A, Kralinsky K, Pevalova L, Dluholucky S, Pisarcíkova M, Hanzen J, Filka J, Sejnova D, Lisková A, Purgelová A, Szovenyová Z, Koren P. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol. 2002; 51: 110-6.
17. Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of rhodotorula isolates. J Clin Microbiol. 2003; 41: 5233-5.
18. Hsueh PR, Teng LJ, Ho SW, Luh KT. Catheter-related sepsis due to Rhodotorula glutinis. J Clin Microbiol. 2003; 41: 857-9.
19. Lo Re V, Fishman NO, Nachamkin I. Recurrent catheter-related Rhodotorularubra infection. Clin Microbiol Infect. 2003; 9: 897-900.
20. Maeder M, Vogt PR, Schaer G, von Graevenitz A, Günthard HF. Aortic homograft endocarditis caused by Rhodotorula mucilaginosa. Infection. 2003; 31: 181-3.
21. Pasqualotto GC, Copetti FA, Meneses CF, Machado ARL, Brunetto AL. Infection by Rhodotorula sp. in children receiving treatment for malignant diseases. J Pediatr Hematol Oncol. 2005; 27: 232-3.
22. Perniola R, Faneschi ML, Manso E, Pizzolante M, Rizzo A, Sticchi Damiani A, Longo R. Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables. Eur J Clin Microbiol Infect Dis. 2006; 25: 193-6.
23. Lunardi LW, Aquino VR, Zimerman RA, Goldani LZ. Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. Clin Infect Dis. 2006; 43: 60-3.
24. Neofytos D, Horn D, De Simone JA. Rhodotorula mucilaginosa catheter-related fungemia in a patient with sickle cell disease: case presentation and literature review. South Med J. 2007; 100: 198-200.
25. Kofteridis D, Mantadakis E, Christidou A, Samonis G. Rhodotorula glutinis fungemia successfully treated with fluconazole: report of two cases. Int J Infect Dis. 2007; 11: 179-87.
26. Pamidimukkala U, Challa S, Lakshmi V, Tandon A, Kulkarni S, Raju SY. Sepsis and meningoencephalitis due to Rhodotorula glutinis in a patient with systemic lupus erythematosus, diagnosed at autopsy. Neurol India. 2007; 55: 304-7.
27. Riedel DJ, Johnson JK, Forrest GN. Rhodotorula glutinis fungemia in a liver-kidney transplant patient. Transplant Infect Dis. 2008; 10: 197-200.
28. De Almeida GM, Costa SF, Melhem M, Motta AL, Szeszs MW, Miyashita F, Pierrotti LC, Rossi F, Burattini MN. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol. 2008; 46: 547-56.
29. Garcia-Suarez J, Gomez-Herruz P, Cuadros JA, Guillen H, Burgaleta C. Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma. Mycoses. 2009; 54: 214-6.
30. Pulvirenti F, Pasqua P, Falzone E, Maffeo F, Gugliara C. Rhodotorula glutinis sepsis. A case report. Infez Med. 2010; 18: 124-6.
31. Al-Obaid I, Khan ZU, Ahmad S, Emara M, Burhama M, Purohit P, Joseph L. Persistent catheter-related Rhodotorula mucilaginosa fungemia in a leukemic child. J Mycol Med. 2011; 21: 134-7.
32. Duggal S, Jain H, Tyagi A, Sharma A, Chugh TD. Rhodotorula fungemia: two cases and a brief review. Med Mycol. 2011; 49: 879-82.
33. Kiehn TE, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheter. Clin Infect Dis. 1992; 14: 841-6.
34. Gomez-Lopez A, Mellado E, Rodriguez-Tuleda JL, Cuenca-Estrella M. Susceptibility profile of 29 isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother. 2005; 55: 312-6.
35. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL. Global antifungal surveillance study. Results from the ARTEMIS DISK global surveillance study, 1997 to 2005: an 8. 5-year analysis of susceptibilities of Candida species and other yeast species to Fluconazole and Voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol. 2007; 45: 1735-45.
36. Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol. 2005; 43: 476-8.
37. EUCAST Antifungal clinical breakpoint table v. 4. 1 valid from 2012-03-14. http://www. eucast. org.
38. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Monzon A, Buitrago MJ, Rodriguez-Tudela JL. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother. 2009; 53: 2192-5.